1Ross R, Glomset JA. The pathogenesis of atherosclerosis [J] . New Engl J Med, 1976,295 (7) :369 - 377.
2Guido Arearo, Beatrice Marina Zenere, Daniela Travia, et al. Non - invasive detection of early endothelial dysfunction in hypercho- lesteolaemic subjects[J]. Atherosclerosis, 1995,114(2)247 - 254.
3Kuzuya M. Probucol as an antioxidant and antiatherogenic drug[J]. Free Radical Biol Med, 1993, 14( 1 ): 67 - 69.
4Engellbery H. Evidence that endogenous heparin activity deficiency may be an important factor in atherogenesis[J] . Atherosclerosis, 1997,23 (2) :159 - 166.
9Hwang S J, Ballantyne CM, Shrrett AR, et al. Circulating adhesion molecules VCAM-1, ICAM-1 and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the atherosclerosis risk in communities (ARIC) study[ J] . Circulation, 1997,96(12) :419 - 422.
8Abusamieh M, Ash G. Atherosclerosis and systemic lupus erythematosus [J]. Cardiology, 2004. 12(5): 267-275.
9Vaudo G, Marchsi S, Gerli R, et al. Endothelial dysfunction in young patients with rheumatoid arthritis and low disearse activity [J]. Ann Rheum Dis, 2004, 63(1):31-35.
10Asia S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine [J]. Adv, Immunol, 1993. 54: 1-78.
